| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 07/27/2011 | CN101401819B Donkey-hide gelatin effervescent particle and preparation method thereof |
| 07/27/2011 | CN101390835B Ribavirin soluble powder |
| 07/27/2011 | CN101385714B Preparation method of DHA lipid nano-particles |
| 07/27/2011 | CN101380311B Diabecron sustained-release tablet and preparation method thereof |
| 07/27/2011 | CN101361890B Traditional Chinese medicine formulation for treating radioactivity skin impairment |
| 07/27/2011 | CN101361789B Traditional Chinese medicine formulation for treating and preventing lung impairment after tumor controlling radiotherapy |
| 07/27/2011 | CN101361771B Compound paclitaxel-oleum fructus bruceae injection emulsion and preparation method thereof |
| 07/27/2011 | CN101357130B Oral microparticles containing pseudoephedrine hydrochloride and cetirizine hydrochloride |
| 07/27/2011 | CN101352534B Chinese medicinal composition, and preparation method and uses thereof |
| 07/27/2011 | CN101348492B Ceftizoxime sodium and preparation thereof |
| 07/27/2011 | CN101347412B Amifostine trihydrate crystal lyophilized preparation and method of preparing the same |
| 07/27/2011 | CN101342250B Bolus for clearing away heat of the upper part of the body |
| 07/27/2011 | CN101336934B Bear bile buccal tablet and preparation process thereof |
| 07/27/2011 | CN101333241B Process for extracting dioscin, preparation thereof and use |
| 07/27/2011 | CN101322816B Chinese medicinal composition for treating scapulohumeral periarthritis |
| 07/27/2011 | CN101322798B Snake bile and Sichuan fritillaria bulb lozenge and preparation thereof |
| 07/27/2011 | CN101306158B Use of traditional Chinese medicine in preparing medicine for treating myocardial infarction |
| 07/27/2011 | CN101306018B Hyper-concentrated placenta tissue hydrolysate freeze-drying capsules and its preparation method |
| 07/27/2011 | CN101296691B Transdermal drug delivery formulation |
| 07/27/2011 | CN101292731B Controllable sustained-release fine particle of phycobiliprotein and preparation method thereof |
| 07/27/2011 | CN101249259B High content and high activity oral polysaccharide-peptide and preparing method and application of the same |
| 07/27/2011 | CN101244240B Quantitative and qualitative analysis method for four turmeric soup preparations |
| 07/27/2011 | CN101244235B Scraping oil, preparation method and application thereof |
| 07/27/2011 | CN101244234B Medicaments for preventing and controlling ischemia and hemorrhagic cerebrovaseular disease, and preparation thereof |
| 07/27/2011 | CN101229130B Isomorellic acid polylactic acid nano particle preparation and preparing method thereof |
| 07/27/2011 | CN101214359B Vulgar acne treating cream |
| 07/27/2011 | CN101214288B Traditional Chinese medicinal composition for treating hepatitis and its preparation |
| 07/27/2011 | CN101214275B Compound red sage root extended release formulation and preparation thereof |
| 07/27/2011 | CN101199576B Medicament prescription for treating coronary heart disease |
| 07/27/2011 | CN101190283B Medicine for treating cervical vertebra disease |
| 07/27/2011 | CN101190268B Compound medicine for treating cervical spondylosis |
| 07/27/2011 | CN101181337B High ester catechin capsule for curing mammary cancer and preparation method thereof |
| 07/27/2011 | CN101180036B Mucoadhesive xyloglucan-containing formulations useful in medical devices and in pharmaceutical formulations |
| 07/27/2011 | CN101152311B Traditional Chinese medicine composition, its preparing method and detection method |
| 07/27/2011 | CN101143152B Dripping pill for treating digestive ulcer and medicine composition containing the same |
| 07/27/2011 | CN101123945B Orally-administrable compositions comprising stable amorphous calcium carbonate |
| 07/27/2011 | CN101108166B Quantitative nano aerosol and method of manufacturing the same |
| 07/27/2011 | CN101095718B Method for preparation of coffee pellets for slimming |
| 07/27/2011 | CN101067146B Biological extraction process of glycyrrhizic acid |
| 07/27/2011 | CN101062167B Preparing method of Chinese medicine composition for treating gynecopathy |
| 07/27/2011 | CN101052384B Non-aqueous transdermal absorption preparation containing non-steroid antiphlogistic analgesic |
| 07/27/2011 | CN101045062B Polyenephophatidylcholine enteric coated preparation, its preparing method and application |
| 07/27/2011 | CN101039699B Methods and compositions for reducing toxicity of a pharmaceutical compound |
| 07/27/2011 | CN101032536B Rhinitis-treating Chinese traditional medicine and its preparation |
| 07/27/2011 | CN101020030B Medicated protecting pad for treating adenomyosis |
| 07/27/2011 | CA2732488A1 Microspheres useful for therapeutic vascular embolization |
| 07/26/2011 | US7985770 Pharmaceutical composition comprising a bi-cyclic compound and method for stabilizing the bi-cyclic compound |
| 07/26/2011 | US7985766 anticholinergic glycopyrrolate or salt and long-acting beta 2 sympathomimetic agent selected from formoterol or salmeterol or salts; chronic obstructive pulmonary disease (COPD) and asthma; inhaled |
| 07/26/2011 | US7985601 Drug delivery vehicle; tissue engineering |
| 07/26/2011 | US7985430 Solid mucoadhesive composition |
| 07/26/2011 | US7985427 geometric shaped enclosures comprising layers of polymers containing drugs, used as drug delivery devices, for sustained release in the intestines; capsules |
| 07/26/2011 | US7985426 Nanoparticles for targeting hepatoma cells and delivery means |
| 07/26/2011 | US7985425 Non-pharmacological method for treating depression, skin disorders and improving overall health and wellness |
| 07/26/2011 | US7985424 Dendritic polymers with enhanced amplification and interior functionality |
| 07/26/2011 | US7985422 A dosage form comprising of a high dose, high solubility active ingredient as modified release and a low dose active ingredient as immediate release where the weight ratio of immediate release active ingredient and modified release |
| 07/26/2011 | US7985421 Sustained release formulations of guaifenesin and additional drug ingredients |
| 07/26/2011 | US7985420 Sustained release of guaifenesin combination drugs |
| 07/26/2011 | US7985419 Divisible tablet and associated methods |
| 07/26/2011 | US7985418 Aliphatic amine polymer salts for tableting |
| 07/26/2011 | US7985417 Method of lipid structure preparation |
| 07/26/2011 | US7985405 Treatment solution and method for preventing posterior capsular opacification by selectively inducing detachment and/or death of lens epithelial cells |
| 07/26/2011 | US7985386 Implantable medical device for diagnostic sensing |
| 07/26/2011 | US7985309 Gas generating device and use of the device in continuous liquid supply |
| 07/26/2011 | US7985198 Device and process for metering solutions |
| 07/26/2011 | CA2621134C Pharmaceutical formulation containing an hmg-coa reductase inhibitor and method for the preparation thereof |
| 07/26/2011 | CA2535401C Emulsive composition containing dapsone |
| 07/26/2011 | CA2533013C Controlled release preparations |
| 07/26/2011 | CA2508611C Compositions of non-steroidal anti-inflammatory drugs, decongestants and anti-histamines |
| 07/26/2011 | CA2485721C Drug delivery device and method for vaporization |
| 07/26/2011 | CA2485385C Lyophilized edible food incorporating a marker |
| 07/26/2011 | CA2422974C Medicaments based on progestins for dermal use |
| 07/26/2011 | CA2405169C Devices and formulations |
| 07/26/2011 | CA2376346C Nucleic acid molecule comprising a nucleic acid sequence which codes for a haemocyanin, and comprising at least one intron sequence |
| 07/26/2011 | CA2333162C Process for producing composite preparation containing nucleic acid |
| 07/26/2011 | CA2267743C Low dose estrogen interrupted hormone replacement therapy |
| 07/21/2011 | WO2011088213A1 Crosslinked hydrogels and methods of making and using thereof |
| 07/21/2011 | WO2011088152A1 Pharmaceutical composition and dosage forms of elinogrel and methods of use thereof |
| 07/21/2011 | WO2011088072A2 Dermal delivery device |
| 07/21/2011 | WO2011087790A1 Triple combination for lowering intraocular pres sure |
| 07/21/2011 | WO2011087765A2 Methods of producing stabilized solid pharmaceutical compositions containing morphinans |
| 07/21/2011 | WO2011087464A1 Sustained release tablet formulation containing etodolac |
| 07/21/2011 | WO2011087403A1 Alcoholysis of glycolipid and corresponding lysis product |
| 07/21/2011 | WO2011087393A1 Composition of vegetal origin for inhaling the smoke generated upon the combustion thereof |
| 07/21/2011 | WO2011086568A1 Controlled release composition for lamotrigine |
| 07/21/2011 | WO2011086505A1 Skin mounted medical patch device |
| 07/21/2011 | WO2011086331A2 Method for manufacturing capsules having controlled head |
| 07/21/2011 | WO2011086210A1 Magnetic-luminescent particles for biomedical uses |
| 07/21/2011 | WO2011086196A1 Antiseptic microspheres |
| 07/21/2011 | WO2011086194A1 Improved oral lysophilisates containing pvp/va |
| 07/21/2011 | WO2011086193A1 Oral lyophilized compositions |
| 07/21/2011 | WO2011086182A2 Pramipexole extended release tablets |
| 07/21/2011 | WO2011086146A1 Halogenated ether complex |
| 07/21/2011 | WO2011086093A2 Pharmaceutical compositions for oral administration of insulin peptides |
| 07/21/2011 | WO2011086078A1 Heterocyclic carboxylic acid derivatives having a 2,5,7-substituted oxazolopyrimidine ring |
| 07/21/2011 | WO2011085957A2 Process for the preparation of pharmaceutical compositions for the sustained release of somatostatin analogs |
| 07/21/2011 | WO2011085484A1 Antimicrobial nitric oxide compositions |
| 07/21/2011 | WO2011065867A3 Liposomes containing oligopeptide fragments of myelin basic protein, a pharmaceutical composition and a method for treatment of multiple sclerosis |
| 07/21/2011 | WO2011064296A9 Pharmaceutical compositions comprising sigma receptor ligands |
| 07/21/2011 | WO2011060195A3 Topical etoricoxib formulation comprising an eutectic mixture of permeation enhancers |
| 07/21/2011 | WO2011045775A4 A delayed release pharmaceutical composition of mesalamine |